Lipids produced within the thymus give immune cells the initial boost they need to fight off infection

September 12, 2012
Immunology: The kick-starters of immune cells
The thymus is a central component of the immune system, and is the site where selected iNKT cells undergo initial activation before migrating to other sites in the body. Credit: iStockphoto.com/janulla

Semi-invariant natural killer T (iNKT) cells wage war against infectious threats, attacking microbial cells and generating signals that enable other immune cells also to respond aggressively. iNKT cells initially undergo activation in the thymus; after being 'switched on' via interaction with certain antigens, they undergo an initial population expansion and then migrate to peripheral immune sites where they proliferate further so they can mount an effective defense.

Some of these activating triggers are foreign in origin, such as bacterial membrane components. However, iNKT cells can also be activated by lipids produced within the thymus itself, as demonstrated in new research from a team led by Gennaro De Libero of the A*STAR Singapore Immunology Network. Previous research had indicated that such 'self' lipids might be an important stimulus. De Libero's team therefore began by treating cultured mouse iNKT cells with lipids isolated from thymic cells and looking for biological signatures of activation. "We found that unusual lipids are important for thymic selection, and that these lipids are produced within unique called peroxisomes," he says.

A peroxisomal enzyme called glyceronephosphate O-acyltransferase (GNPAT) plays a central role in producing these particular lipids. Accordingly, the researchers observed that iNKT cell maturation tended to stall in mice lacking GNPAT, and these animals had considerably fewer functional iNKT cells than normal mice. Subsequent transplantation experiments demonstrated that immature iNKT cells from wild-type mice are less likely to reach full maturity when grafted into thymuses of GNPAT-deficient mice. Collectively, these experiments demonstrate that a substantial subset of developing iNKT cells is dependent on interactions with peroxisomally produced lipids in the thymus in order to undergo full activation.

Despite the team's revelation of  insightful details about the development of these important , a number of mysteries remain—for example, how mature iNKTs learn to stop targeting the that switched them on in the first place. "Now that we know the stimulatory self lipids, we can address the mechanisms which reduce iNKT reactivity against them in the periphery," explains De Libero. This would provide a means to avoid autoimmune attacks.

In parallel, he and his colleagues intend to determine whether foreign lipids also trigger immune cell maturation via a similar mechanism. "For example, T cells that recognize mycobacterial lipids are important in protecting people from tuberculosis," he says, "and it will be important to study how these cells are selected and mature within the thymus."

Explore further: Scientists discover special class of natural fats stimulates immune cells to fight diseases

More information: Facciotti, F., Ramanjaneyulu, G. S., Lepore, M., Sansano, S., Cavallari, M., et al. Peroxisome-derived lipids are self antigens that stimulate invariant natural killer T cells in the thymus. Nature Immunology 13, 474–480 (2012). www.nature.com/ni/journal/v13/n5/abs/ni.2245.html

Related Stories

Scientists discover special class of natural fats stimulates immune cells to fight diseases

April 2, 2012
An international research team led by scientists from Singapore Immunology Network (SIgN) under the Agency of Science, Technology and Research (A*STAR) discovered that a special class of fatty molecules is essential for activating ...

Research describes advantages of new vaccine adjuvant

December 12, 2011
New research from the laboratory of Dr. Elizabeth Leadbetter at the Trudeau Institute may lead to a whole new class of vaccines. Dr. Leadbetter's lab has discovered new properties of a potential vaccine adjuvant that suggest ...

Improving psoriasis with GLP-1 analogue therapy

December 13, 2011
(Medical Xpress) -- UCD clinician scientists and researchers from NUI Maynooth and Trinity College led by Conway Fellow, Professor Donal O’Shea have reported an improvement in the severity of psoriasis in patients following ...

Recommended for you

Drug increases speed, safety of treatment for multiple food allergies

December 11, 2017
In a randomized, controlled phase-2 clinical trial, an asthma medication increased the speed and safety of a protocol used to treat children for several food allergies at once, according to a study by researchers at the Stanford ...

Immunotherapy drug nearly eliminates severe acute graft-versus-host disease

December 9, 2017
Results from a phase 2 clinical trial, presented by Seattle Children's Research Institute at the 59th American Society of Hematology (ASH) Annual Meeting, show that the drug Abatacept (Orencia) nearly eliminated life-threatening ...

Location, location, location: Immunization delivery site matters

December 1, 2017
In vaccination, a certain subpopulation of dendritic cells is vital to triggering the body's adaptive immune system, report researchers at The Jackson Laboratory (JAX), Yale University and Astra-Zeneca.

An anti-aging protein could be targeted to rejuvenate immune cells

November 30, 2017
Anti-aging proteins have long been shown to protect against age-related diseases, such as cancer, neurodegeneration, and cardiovascular disease. A study by researchers at the Gladstone Institutes now reveals that one such ...

Scientists find key to miscarriages in blood clotting disorder

November 28, 2017
Monash University researchers have potentially shed light on why women with the rare autoimmune disorder Antiphospholipid syndrome (APS) are prone to successive pregnancy losses.

How do cells release IL-1? After three decades, now we know

November 28, 2017
Researchers at Boston Children's Hospital have identified, for the first time, the molecule that enables immune cells to release interleukin-1 (IL-1), a key part of our innate immune response to infections. Findings were ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.